Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14,280 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combination of the chemokine receptor type 2 (CCR2) antagonist DMX-200 and candesartan for COVID-19: a randomised controlled trial.
O'Hara DV, Bassi A, Wilcox A, Jha V, Rathore V, D'Cruz S, Snelling TL, Jones M, Totterdell J, Bangi A, Jain MK, Pollock C, Burrell L, Fox G, Jones C, Kotwal S, Faridah Syed Omar S, Jardine M; CLARITY 2.0 trial investigators. O'Hara DV, et al. Among authors: jones c, jones m. BMJ Open. 2024 Oct 22;14(10):e081790. doi: 10.1136/bmjopen-2023-081790. BMJ Open. 2024. PMID: 39438096 Free PMC article. Clinical Trial.
A Randomized Trial of Nafamostat for Covid-19.
Morpeth SC, Venkatesh B, Totterdell JA, McPhee GM, Mahar RK, Jones M, Bandara M, Barina LA, Basnet BK, Bowen AC, Burke AJ, Cochrane B, Denholm JT, Dhungana A, Dore GJ, Dotel R, Duffy E, Dummer J, Foo H, Gilbey TL, Hammond NE, Hudson BJ, Jha V, Jevaji PR, John O, Joshi R, Kang G, Kaur B, Kim S, Das SK, Lau JSY, Littleford R, Marsh JA, Marschner IC, Matthews G, Maze MJ, McArthur CJ, McFadyen JD, McMahon JH, McQuilten ZK, Molton J, Mora JM, Mudaliar V, Nguyen V, O'Sullivan MVN, Pant S, Park JE, Paterson DL, Price DJ, Raymond N, Rees MA, Robinson JO, Rogers BA, Ryu WS, Sasadeusz J, Shum O, Snelling TL, Sommerville C, Trask N, Lewin SR, Hills TE, Davis JS, Roberts JA, Tong SYC. Morpeth SC, et al. Among authors: jones m. NEJM Evid. 2023 Nov;2(11):EVIDoa2300132. doi: 10.1056/EVIDoa2300132. Epub 2023 Oct 18. NEJM Evid. 2023. PMID: 38320527 Clinical Trial.
TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of randomized clinical trials of nafamostat and camostat mesylate.
Hernández-Mitre MP, Morpeth SC, Venkatesh B, Hills TE, Davis J, Mahar RK, McPhee G, Jones M, Totterdell J, Tong SYC, Roberts JA. Hernández-Mitre MP, et al. Among authors: jones m. Clin Microbiol Infect. 2024 Jun;30(6):743-754. doi: 10.1016/j.cmi.2024.01.029. Epub 2024 Feb 6. Clin Microbiol Infect. 2024. PMID: 38331253
Erratum to 'TMPRSS2 inhibitors for the treatment of COVID-19 in adults: a systematic review and meta-analysis of randomized clinical trials of nafamostat and camostat mesylate' [Clin Microbiol Infect (30) (2024) 743-754].
Hernández-Mitre MP, Morpeth SC, Venkatesh B, Hills TE, Davis J, Mahar RK, McPhee G, Jones M, Totterdell J, Tong SYC, Roberts JA. Hernández-Mitre MP, et al. Among authors: jones m. Clin Microbiol Infect. 2025 Jan;31(1):141. doi: 10.1016/j.cmi.2024.08.005. Epub 2024 Aug 8. Clin Microbiol Infect. 2025. PMID: 39122115 No abstract available.
Trimodal skin health programme for childhood impetigo control in remote Western Australia (SToP): a cluster randomised, stepped-wedge trial.
Thomas HMM, Enkel SL, Mullane M, McRae T, Barnett TC, Carapetis JR, Christophers R, Coffin J, Famlonga R, Jacky J, Jones M, Marsh J, McIntosh K, O'Donnell V, Pan E, Pearson G, Sibosado S, Smith B, Snelling T, Steer A, Tong SYC, Walker R, Whelan A, White K, Wright E, Bowen AC; SToP Trial. Thomas HMM, et al. Among authors: jones m. Lancet Child Adolesc Health. 2024 Nov;8(11):809-820. doi: 10.1016/S2352-4642(24)00229-3. Epub 2024 Oct 9. Lancet Child Adolesc Health. 2024. PMID: 39393383 Clinical Trial.
Multi-methods process evaluation of the SToP (See, Treat, Prevent) trial: a cluster randomised, stepped wedge trial to support healthy skin.
Thomas HMM, Mullane M, Enkel SL, McRae T, Amgarth-Duff I, Carapetis JR, Coffin J, Christophers R, Famlonga R, Jacky J, Jones M, Marsh J, McIntosh K, O'Donnell V, Pan E, Pearson G, Sibosado S, Smith B, Snelling T, Steer A, Tong SYC, Walker R, Whelan A, White K, Wright E, Bowen AC; SToP (See, Treat, Prevent skin sores and scabies) Trial. Thomas HMM, et al. Among authors: jones m. EClinicalMedicine. 2024 Oct 9;77:102793. doi: 10.1016/j.eclinm.2024.102793. eCollection 2024 Nov. EClinicalMedicine. 2024. PMID: 39649132 Free PMC article.
Impact of time to first antimicrobial dose on length of stay and 30-day hospital readmission in patients with lower limb cellulitis.
Bishop JL, Jones M, Farquharson J, Summerhayes K, Tucker R, Smith M, Cowan R, Friedman ND, Schulz TR, Kong DCM, Buising KL. Bishop JL, et al. Among authors: jones m. J Glob Antimicrob Resist. 2021 Jun;25:367-369. doi: 10.1016/j.jgar.2021.04.007. Epub 2021 May 12. J Glob Antimicrob Resist. 2021. PMID: 33991747 Free article.
14,280 results
You have reached the last available page of results. Please see the User Guide for more information.